AVIRMAX
Avirmax is a Delaware corporation that focuses on adeno-associated virus research, development, and manufacturing. It develops novel technologies to address current issues in viral vector generation. Avirmax is located in Hayward, California.
AVIRMAX
Industry:
Bioinformatics Biotechnology Manufacturing
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.avirmax.com
Total Employee:
11+
Status:
Active
Contact:
1(510) 397-2333
Email Addresses:
[email protected]
Technology used in webpage:
Cloudflare Hosting ReCAPTCHA V2
Similar Organizations
Atrium Medical
Atrium Medical Corporation, a healthcare company, engages in the research and development, design, and manufacture of medical device
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
dpiX
dpiX is a a-Si technology firm that focuses on research, engineering, development, and manufacturing.
G-Biosciences
G-Biosciences is a cGMP compliant life sciences laboratory that is experienced in academic and industrial research and manufacturing.
Pace Diagnostics
Pace Diagnostics is a biotech firm specializing in diagnostics research, development, licencing, manufacturing, and marketing.
Current Employees Featured
Investors List
Kaitai Capital
Kaitai Capital investment in Venture Round - Avirmax
Official Site Inspections
http://www.avirmax.com Semrush global rank: 7.03 M Semrush visits lastest month: 919
- Host name: 172.67.149.138
- IP address: 172.67.149.138
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avirmax"
Avirmax Inc
Avirmax Biopharma, Inc. based in San Francisco Bay Area, is a preclinical stage biopharmaceutical company focusing on innovation and development of genetic medicines to treat chronic and degenerated ocular diseases. Enter ABI …See details»
Avirmax - Crunchbase Company Profile & Funding
Avirmax is a Delaware corporation that focuses on adeno-associated virus research, development, and manufacturing. It develops novel technologies to …See details»
Avirmax Biopharma
Avirmax Biopharma, Inc. based in San Francisco Bay Area, is a preclinical stage biopharmaceutical company focusing on innovation and development of genetic medicines to treat chronic and degenerated ocular diseases using integrated …See details»
Avirmax, Inc. - LinkedIn
Avirmax, Inc. based in San Francisco Bay Area, is dedicated to innovate, develop and manufacture adeno-associated virus (AAV) vector mediated biotherapeutics using its …See details»
Avirmax, Inc. Information - RocketReach
Avirmax, Inc is dedicated to innovate and develop novel technologies to address current challenges in viral vector production based on its state of the art AAV bioprocess technologies …See details»
Avirmax, Inc. Overview | SignalHire Company Profile
Avirmax, Inc. based in San Francisco Bay Area, is dedicated to innovate, develop and manufacture adeno-associated virus (AAV) vector mediated biotherapeutics using its …See details»
Avirmax Biopharma - VentureRadar
Avirmax Biopharma, Inc. based in San Francisco Bay Area, is a preclinical stage biopharmaceutical company focusing on innovation and development of genetic medicines to …See details»
AVIRMAX, INC. Company Profile | Hayward, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AVIRMAX, INC. of Hayward, CA. Get the latest business insights from Dun & Bradstreet.See details»
Avirmax Company Profile 2024: Valuation, Funding & Investors
Avirmax General Information Description. Developer of gene therapy drugs intended to target chronic eye diseases. The company specializes in developing biotherapeutics using its …See details»
Avirmax Biopharma Inc. - Drug pipelines, Patents, Clinical trials
Avirmax Biopharma has completed cGMP manufacturing of ABI-110 using VSafâ„¢ rAAV Production Platform with Sf-rhabdovirus free Sf9 cells and presently prepares regulatory …See details»
About – Avirmax Biopharma
Avirmax Biopharma, Inc. based in San Francisco Bay Area, is a preclinical stage biopharmaceutical company focusing on innovation and development of genetic medicines to treat chronic and degenerated ocular diseases using integrated …See details»
About – Avirmax CMC
Avirmax, Inc. based in San Francisco Bay Area, is dedicated to the innovation, development, and manufacture of adeno-associated virus (AAV) vector mediated biotherapeutics using its …See details»
Avirmax - Products, Competitors, Financials, Employees, …
Avirmax Biopharma, Inc. is a preclinical stage biopharmaceutical company focusing on the development of genetic medicines for chronic and degenerative ocular diseases. The …See details»
Avirmax - Overview, News & Similar companies | ZoomInfo.com
May 17, 2023 Avirmax Biopharma Inc. Will Present at the 26th ASGCT 2023 Annual Conference in Los Angeles HAYWARD, Calif., May 17, 2023 /PRNewswire/ -- Avirmax Biopharma Inc. …See details»
Avirmax - F6S
Avirmax, Inc. based in San Francisco Bay Area, is dedicated to innovate, develop and manufacture adeno-associated virus (AAV) vector mediated biotherapeutics using its …See details»
Avirmax - workinbiotech.com
Avirmax is developing adeno-associated virus (AAV)-mediated gene therapy drugs that target chronic eye diseases. Recombinant AAVs (rAAVs) are promising vectors for gene therapy as …See details»
Avirmax Biopharma Inc receives IND approval from FDA - Modern …
Jun 6, 2024 Shengjiang Shawn Liu, PhD, CEO of Avirmax Biopharma, commented on the significance of the IND approval in a press release from the company. "We are thrilled to have …See details»
Founding and Management Team – Avirmax Biopharma
Dr. Liu is an experienced biotechnologist, virologist, biochemist and serial entrepreneur. Prior to Avirmax, Dr. Liu held an executive position, chief scientist and global head of Pathogen Safety …See details»
Avirmax Inc - ARVO 2025
Avirmax Inc. is an integrated gene therapy platform company dedicated to: · AAV capsid engineering with multiple proprietary capsids ready for human trial; · Multiple innovative AAV …See details»
Technologies – Avirmax Biopharma
AVIRMAX TECHNOLOGIES. AAV Capsid Engineering. Gene therapy (GT) is bound to be the future of biomedicine. Recombinant AAVs (rAAVs) are the most promising vectors because …See details»